Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Precision Epigenomics Selected for 2024 Flinn Foundation Bioscience Entrepreneurship ProgramBy: Precision Epigenomics Inc "We are honored to be recognized by the Flinn Foundation for our innovative approach to earlier cancer detection and to have the opportunity to work with the AZ Bioscience Roadmap team. The currently recommended conventional screening methods for cancer underperform and they do not detect most cancer types that are killing people," said Mark Nelson, Ph.D., Co-Founder and Chief Executive Officer of Precision Epigenomics. "Our goal is to change the way cancers are detected." "The experienced Arizona Biosciences mentors who are so generous with their time will make an impact refining our ongoing commercialization pathway," said Richard Bernert, M.D., COO of Precision Epigenomics. Joshua Routh, M.D., Medical Director for the group added, "We look forward to utilizing the Flinn Foundation resources so that we can begin to achieve better patient outcomes through earlier cancer detection with our EPISEEKTM assay. Earlier detection saves lives." About Precision Epigenomics Precision Epigenomics Inc (https://precision- About Flinn Foundation The Flinn Foundation (https://flinn.org/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|